BioSample	Run	ReleaseDate	LoadDate	spots	bases	spots_with_mates	avgLength	size_MB	AssemblyName	download_path	Experiment	LibraryName	LibraryStrategy	LibrarySelection	LibrarySource	LibraryLayout	InsertSize	InsertDev	Platform	Model	SRAStudy	BioProject	Study_Pubmed_id	ProjectID	Sample	SampleType	TaxID	ScientificName	SampleName	g1k_pop_code	source	g1k_analysis_group	Subject_ID	Sex.x	Disease	Tumor	Affection_Status	Analyte_Type	Histological_Type	Body_Site	CenterName	Submission	dbgap_study_accession	Consent	RunHash	ReadHash	uid	title	organization	taxonomy	sra	geo	Sex.y	brca mutation	cell line	kinase mutation	source_name	tp53 mutation	treatment
SAMN18490632	SRR14068810	2022-02-15T16:49:13Z	2021-03-25T18:32:11Z	24117020	4823404000	24117020	200	1420		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068810/SRR14068810.lite.1	SRX10443203		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575304	simple	9606	Homo sapiens	GSM5211117							no					GEO	SRA1210264		public	37B50C19FD1472E625C72AF6DA44E239	CFA87AEE76F0AF0BCCF9E39332FAAC72	18490632	OVCAR4_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575304	GSM5211117	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490632	SRR14068811	2022-02-15T16:49:13Z	2021-03-25T19:00:21Z	23946298	4789259600	23946298	200	1413		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068811/SRR14068811.lite.1	SRX10443203		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575304	simple	9606	Homo sapiens	GSM5211117							no					GEO	SRA1210264		public	A73B9666ED63541D7D4C466DF049F4BE	93107DA8FEFBBBC72C3E6C28B1F62449	18490632	OVCAR4_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575304	GSM5211117	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490633	SRR14068796	2022-02-15T16:49:13Z	2021-03-25T14:20:11Z	11630777	2326155400	11630777	200	689		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068796/SRR14068796.lite.1	SRX10443196		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575297	simple	9606	Homo sapiens	GSM5211110							no					GEO	SRA1210264		public	4AC27055CA9D306894246B28668E83D5	A04D41FF80A4EE05B01D44EC6D76CBDE	18490633	TYKnu_Baseline_flowcell 1	University of Newcastle	9606	SRS8575297	GSM5211110	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490633	SRR14068797	2022-02-15T16:49:13Z	2021-03-25T14:53:30Z	12905566	2581113200	12905566	200	774		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos1/sra-pub-zq-38/SRR014/14068/SRR14068797/SRR14068797.lite.1	SRX10443196		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575297	simple	9606	Homo sapiens	GSM5211110							no					GEO	SRA1210264		public	B137F7C1858AAC09AC359AAABBB9D807	99B49731ED39072AFE4A098DD303DEB2	18490633	TYKnu_Baseline_flowcell 1	University of Newcastle	9606	SRS8575297	GSM5211110	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490634	SRR14068794	2022-02-15T16:49:13Z	2021-03-25T14:33:16Z	10211030	2042206000	10211030	200	588		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068794/SRR14068794.lite.1	SRX10443195		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575296	simple	9606	Homo sapiens	GSM5211109							no					GEO	SRA1210264		public	575CA692799B417EF9A2FF52CFA35DE8	2FE2053881D85DCF1EA49CED7811B461	18490634	OVCAR4_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575296	GSM5211109	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490634	SRR14068795	2022-02-15T16:49:13Z	2021-03-25T14:39:38Z	11333063	2266612600	11333063	200	658		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068795/SRR14068795.lite.1	SRX10443195		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575296	simple	9606	Homo sapiens	GSM5211109							no					GEO	SRA1210264		public	DDFFE6FFE914996F28E27189543EF941	6A11FA9FCD877405D5D718586D1DD976	18490634	OVCAR4_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575296	GSM5211109	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490635	SRR14068792	2022-02-15T16:49:13Z	2021-03-25T14:42:53Z	11714778	2342955600	11714778	200	681		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos1/sra-pub-zq-38/SRR014/14068/SRR14068792/SRR14068792.lite.1	SRX10443194		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575295	simple	9606	Homo sapiens	GSM5211108							no					GEO	SRA1210264		public	AAF11076B28569D8769356B9BC87BA56	7F091B0A56D7BA8647A5C6367FDA13C7	18490635	OVCAR4_Baseline_flowcell 1	University of Newcastle	9606	SRS8575295	GSM5211108	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490635	SRR14068793	2022-02-15T16:49:13Z	2021-03-25T14:54:54Z	12953905	2590781000	12953905	200	761		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068793/SRR14068793.lite.1	SRX10443194		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575295	simple	9606	Homo sapiens	GSM5211108							no					GEO	SRA1210264		public	EE409EF851D93B599DEE205AA2BD74DA	542B128A0FB0C901DD2380EC3053F61C	18490635	OVCAR4_Baseline_flowcell 1	University of Newcastle	9606	SRS8575295	GSM5211108	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490636	SRR14068790	2022-02-15T16:49:13Z	2021-03-25T14:25:39Z	9825421	1965084200	9825421	200	568		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068790/SRR14068790.lite.1	SRX10443193		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575294	simple	9606	Homo sapiens	GSM5211107							no					GEO	SRA1210264		public	8E595701B5C52DEA07A50E9368AC23B0	1CECD3CE20938E61574E3DD5B34D5782	18490636	OAW28_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575294	GSM5211107	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490636	SRR14068791	2022-02-15T16:49:13Z	2021-03-25T14:37:14Z	10952187	2190437400	10952187	200	639		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos1/sra-pub-zq-38/SRR014/14068/SRR14068791/SRR14068791.lite.1	SRX10443193		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575294	simple	9606	Homo sapiens	GSM5211107							no					GEO	SRA1210264		public	6B0BC0E7F75D01068FD0EDF933DC01F8	9401FFD2E9B146B53F01045BB0769B76	18490636	OAW28_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575294	GSM5211107	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490637	SRR14068788	2022-02-15T16:49:13Z	2021-03-25T14:34:32Z	12193761	2438752200	12193761	200	724		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068788/SRR14068788.lite.1	SRX10443192		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575293	simple	9606	Homo sapiens	GSM5211106							no					GEO	SRA1210264		public	142097ECF6D37C97E3F6CC860F24A5AC	9EE55D4BEDF90DF614C6171CB42A874B	18490637	OAW28_Baseline_flowcell 1	University of Newcastle	9606	SRS8575293	GSM5211106	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490637	SRR14068789	2022-02-15T16:49:13Z	2021-03-25T15:09:34Z	13447013	2689402600	13447013	200	808		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068789/SRR14068789.lite.1	SRX10443192		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575293	simple	9606	Homo sapiens	GSM5211106							no					GEO	SRA1210264		public	527EDC49D5E5974DE4B14B65F4FCE59C	0D0675BEFAD17D8989E4F17A45162739	18490637	OAW28_Baseline_flowcell 1	University of Newcastle	9606	SRS8575293	GSM5211106	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490638	SRR14068786	2022-02-15T16:49:13Z	2021-03-25T14:24:10Z	10103331	2020666200	10103331	200	585		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068786/SRR14068786.lite.1	SRX10443191		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575292	simple	9606	Homo sapiens	GSM5211105							no					GEO	SRA1210264		public	39C84F15893432CD94B159DE28A39A46	4ED32E51894B002FEEDFCA1ED03B5D4B	18490638	COV362_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575292	GSM5211105	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490638	SRR14068787	2022-02-15T16:49:13Z	2021-03-25T14:38:11Z	11149379	2229875800	11149379	200	653		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068787/SRR14068787.lite.1	SRX10443191		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575292	simple	9606	Homo sapiens	GSM5211105							no					GEO	SRA1210264		public	A37A791AA585C20E5C6F68ADFF917DAB	4637436773F3052E27BE4E8AD0BAFFE7	18490638	COV362_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575292	GSM5211105	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490639	SRR14068784	2022-02-15T16:49:13Z	2021-03-25T14:35:58Z	10943873	2188774600	10943873	200	660		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068784/SRR14068784.lite.1	SRX10443190		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575291	simple	9606	Homo sapiens	GSM5211104							no					GEO	SRA1210264		public	4AB8C5D716317B702B52369D3497F5BD	261BD76B2392F7389DD8D6608B6E6420	18490639	COV362_Baseline_flowcell 1	University of Newcastle	9606	SRS8575291	GSM5211104	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490639	SRR14068785	2022-02-15T16:49:13Z	2021-03-25T14:44:46Z	11942541	2388508200	11942541	200	730		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos3/sra-pub-zq-24/SRR014/14068/SRR14068785/SRR14068785.lite.1	SRX10443190		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575291	simple	9606	Homo sapiens	GSM5211104							no					GEO	SRA1210264		public	9C080E2BF3BBF8D6DEDFF74FA581AF4E	89C395188783FD780EF5EA65540CB1A8	18490639	COV362_Baseline_flowcell 1	University of Newcastle	9606	SRS8575291	GSM5211104	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490648	SRR14068814	2022-02-15T16:49:13Z	2021-03-25T17:35:08Z	26636265	5327253000	26636265	200	1591		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068814/SRR14068814.lite.1	SRX10443205		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575307	simple	9606	Homo sapiens	GSM5211119							no					GEO	SRA1210264		public	52F574A364F2F9959543003F4C204333	FE1F99C46B37B268C3BC5AEC256F0481	18490648	TYKnu_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575307	GSM5211119	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490648	SRR14068815	2022-02-15T16:49:13Z	2021-03-25T18:46:21Z	26399040	5279808000	26399040	200	1579		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068815/SRR14068815.lite.1	SRX10443205		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575307	simple	9606	Homo sapiens	GSM5211119							no					GEO	SRA1210264		public	6C929958C4BF2615244FEED719F2CEB9	966E2EA12E27FC142801F2FB9B7A86B9	18490648	TYKnu_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575307	GSM5211119	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490649	SRR14068812	2022-02-15T16:49:13Z	2021-03-25T18:58:05Z	28263840	5652768000	28263840	200	1743		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068812/SRR14068812.lite.1	SRX10443204		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575305	simple	9606	Homo sapiens	GSM5211118							no					GEO	SRA1210264		public	BC979E54A7B40A63C6642C6D963FB991	190F15DFDD3CC0CB90167A90A4769BA7	18490649	TYKnu_Untreated_flowcell 2	University of Newcastle	9606	SRS8575305	GSM5211118	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490649	SRR14068813	2022-02-15T16:49:13Z	2021-03-25T17:31:55Z	27984770	5596954000	27984770	200	1729		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068813/SRR14068813.lite.1	SRX10443204		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575305	simple	9606	Homo sapiens	GSM5211118							no					GEO	SRA1210264		public	C00F999C36E13347FE06D652C4C9EC61	697677983E97CAC9FAA85C28AF6BAF19	18490649	TYKnu_Untreated_flowcell 2	University of Newcastle	9606	SRS8575305	GSM5211118	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Untreated
SAMN18490650	SRR14068808	2022-02-15T16:49:13Z	2021-03-25T18:52:05Z	27751350	5550270000	27751350	200	1670		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068808/SRR14068808.lite.1	SRX10443202		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575303	simple	9606	Homo sapiens	GSM5211116							no					GEO	SRA1210264		public	C8D53624BBB1CA771F77BCDEA744515E	8986C1E879A678BFC4A19F03CC5BBA91	18490650	OVCAR4_Untreated_flowcell 2	University of Newcastle	9606	SRS8575303	GSM5211116	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490650	SRR14068809	2022-02-15T16:49:13Z	2021-03-25T19:52:04Z	27598939	5519787800	27598939	200	1664		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068809/SRR14068809.lite.1	SRX10443202		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575303	simple	9606	Homo sapiens	GSM5211116							no					GEO	SRA1210264		public	951801251436E8893D682FC9482213F2	BCD67DDE44E01FC9D9C41DCB12A42BFD	18490650	OVCAR4_Untreated_flowcell 2	University of Newcastle	9606	SRS8575303	GSM5211116	female		OVCAR4		ovarian cancer cell line	TP53 c.388C>G; p.Leu130Val	Untreated
SAMN18490651	SRR14068806	2022-02-15T16:49:13Z	2021-03-25T18:15:57Z	23421616	4684323200	23421616	200	1389		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068806/SRR14068806.lite.1	SRX10443201		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575302	simple	9606	Homo sapiens	GSM5211115							no					GEO	SRA1210264		public	C82060103770F9CE9D31DEC0B06A2CAF	51F0C12F74636406FD47B6265FBE8B7D	18490651	OAW28_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575302	GSM5211115	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490651	SRR14068807	2022-02-15T16:49:13Z	2021-03-25T18:01:36Z	23248759	4649751800	23248759	200	1382		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068807/SRR14068807.lite.1	SRX10443201		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575302	simple	9606	Homo sapiens	GSM5211115							no					GEO	SRA1210264		public	FCB4FF8FD3591BF4DA873DD6D7A3FC7C	AD696A1E7E18CEF458377B35986F514C	18490651	OAW28_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575302	GSM5211115	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490652	SRR14068804	2022-02-15T16:49:13Z	2021-03-25T18:54:44Z	29421911	5884382200	29421911	200	1808		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068804/SRR14068804.lite.1	SRX10443200		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575300	simple	9606	Homo sapiens	GSM5211114							no					GEO	SRA1210264		public	BB0DB06ED3F2EBA1C2F248C195DCA3FF	58471B7DBD1D4765F00EB2AFE865AAF1	18490652	OAW28_Untreated_flowcell 2	University of Newcastle	9606	SRS8575300	GSM5211114	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490652	SRR14068805	2022-02-15T16:49:13Z	2021-03-25T19:08:52Z	29299921	5859984200	29299921	200	1803		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068805/SRR14068805.lite.1	SRX10443200		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575300	simple	9606	Homo sapiens	GSM5211114							no					GEO	SRA1210264		public	2F19BC8C06F4FCD18550A50CA6C3394E	4A8A5044555D2A1C33FAC4A035E02C11	18490652	OAW28_Untreated_flowcell 2	University of Newcastle	9606	SRS8575300	GSM5211114	female		OAW28		ovarian cancer cell line	TP53 c.455delC; p.Pro152Argfs*18	Untreated
SAMN18490653	SRR14068802	2022-02-15T16:49:13Z	2021-03-25T18:26:11Z	23589083	4717816600	23589083	200	1402		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068802/SRR14068802.lite.1	SRX10443199		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575299	simple	9606	Homo sapiens	GSM5211113							no					GEO	SRA1210264		public	558413DA61136D8481372D62021A022D	9DAF39CC41B928D760841893C5F9DE5D	18490653	COV362_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575299	GSM5211113	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490653	SRR14068803	2022-02-15T16:49:13Z	2021-03-25T18:09:26Z	23466400	4693280000	23466400	200	1397		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068803/SRR14068803.lite.1	SRX10443199		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575299	simple	9606	Homo sapiens	GSM5211113							no					GEO	SRA1210264		public	0EE190BE039AD5CBA38EC0FBD597BC6B	9C0FC3C2C1543853799BE2DFA07620FE	18490653	COV362_Azacitidine carboplatin_flowcell 2	University of Newcastle	9606	SRS8575299	GSM5211113	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490654	SRR14068800	2022-02-15T16:49:13Z	2021-03-25T19:09:44Z	25100426	5020085200	25100426	200	1571		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068800/SRR14068800.lite.1	SRX10443198		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575301	simple	9606	Homo sapiens	GSM5211112							no					GEO	SRA1210264		public	F9C1B0910EF1993AE6B146C6A095E2E9	62775389F3531DBF7790763142D9858C	18490654	COV362_Untreated_flowcell 2	University of Newcastle	9606	SRS8575301	GSM5211112	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490654	SRR14068801	2022-02-15T16:49:13Z	2021-03-25T17:20:27Z	25032346	5006469200	25032346	200	1569		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068801/SRR14068801.lite.1	SRX10443198		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575301	simple	9606	Homo sapiens	GSM5211112							no					GEO	SRA1210264		public	53CA4A5F9D811BCE1D4772B810B89EF2	400DBF903018D9F107923E80DFEE3423	18490654	COV362_Untreated_flowcell 2	University of Newcastle	9606	SRS8575301	GSM5211112	female	BRCA1 c.4095+1G>T; p.Pro871fs (c.2611_2612ins1)	COV362		ovarian cancer cell line	TP53 c.659A>G; p.Tyr220Cys	Untreated
SAMN18490655	SRR14068798	2022-02-15T16:49:13Z	2021-03-25T14:33:22Z	11174809	2234961800	11174809	200	646		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068798/SRR14068798.lite.1	SRX10443197		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575298	simple	9606	Homo sapiens	GSM5211111							no					GEO	SRA1210264		public	549A3B6F1C6428A1372DE896FF29634D	8B349596922DBBD6E7092CEA24094D60	18490655	TYKnu_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575298	GSM5211111	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
SAMN18490655	SRR14068799	2022-02-15T16:49:13Z	2021-03-25T14:45:21Z	12386490	2477298000	12386490	200	723		https://sra-downloadb.be-md.ncbi.nlm.nih.gov/sos4/sra-pub-zq-1/SRR014/14068/SRR14068799/SRR14068799.lite.1	SRX10443197		RNA-Seq	cDNA	TRANSCRIPTOMIC	PAIRED	0	0	ILLUMINA	Illumina HiSeq 2000	SRP312119	PRJNA717226	3	717226	SRS8575298	simple	9606	Homo sapiens	GSM5211111							no					GEO	SRA1210264		public	B945CC2459C70A6084799A827E084AA6	1092826A19B97AD4F201D091A4DE56D7	18490655	TYKnu_Azacitidine carboplatin_flowcell 1	University of Newcastle	9606	SRS8575298	GSM5211111	female		TYKnu	NRAS c.35G>A; p.Gly12Asp NRAS c.181C>A; p.Gln61Lys	ovarian cancer cell line	TP53c.524G>A; p.Arg175His	Treated with 5µM azacitidine and 20µM carboplatin
